MDalert.com is designed to help physicians in all specialties succeed in this new world of performance-driven healthcare.
May 6, 2021

More Patients Had Healthcare Visits for Atopic Dermatitis and Itch After California Wildfires

By Jeff Craven /alert Contributor

A tertiary care center approximately 175 miles away from the source of a California wildfire in late 2018 and early 2019 saw an increase in the number of patient visits for atopic dermatitis (AD) and pruritis...

 
More Patients Had Healthcare Visits for Atopic Dermatitis and Itch After California Wildfires
May 3, 2021

SWORD-1: Novel RET Inhibitor Appears Safe, Effective

By Adam Hochron

A phase 1/2 clinical trial for an investigational RET 1 inhibitor showed positive findings, including tumor regression and general tolerability...

SWORD-1: Novel RET Inhibitor Appears Safe, Effective
April 28, 2021

FDA Approves Loncastuximab Tesirine-lpyl for Large B Cell Lymphoma

By Cassie Homer

The FDA granted accelerated approval to loncastuximab tesirine-lpyl (Zynlonta, ADC Therapeutics SA) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy...

 
FDA Approves Loncastuximab Tesirine-lpyl for Large B Cell Lymphoma
April 14, 2021

Experts Recommend Strategies for Antibiotic Use in Pediatric Patients With Hematologic Malignancies

By Cameron Kelsall, /alert Contributor

An expert panel convened by 8th European Congress on Infections in Leukemia has issued guidelines for the use of antibiotic therapy in pediatric patients with leukemia and lymphoma...

 
Experts Recommend Strategies for Antibiotic Use in Pediatric Patients With Hematologic Malignancies
April 13, 2021

European Committee Endorses Atezolizumab as First-Line NSCLC Treatment

By Adam Hochron

The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended approval of atezolizumab as a first-line treatment for adults with metastatic non-small cell lung cancer...

 
European Committee Endorses Atezolizumab as First-Line NSCLC Treatment
View More
Loading...

Trending News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Reuters Health Medical News

Pregnant COVID-19 patients have low in-hospital mortality rates

By Lisa Rapaport (Reuters Health) - Women hospitalized with COVID-19 appear to have lower mortality rates when they're pregnant than those who are not pregnant, even when they're admitted to intensive Read More »

U.S. authorizes Pfizer/BioNTech COVID vaccine for children 12 to 15

By Michael Erman (Reuters) - U.S. regulators on Monday authorized Pfizer and BioNTech's COVID-19 vaccine for use in children as young as 12, widening the country's inoculation program as vaccination Read More »

U.S. authorizes Pfizer/BioNTech COVID vaccine for children 12 to 15

By Reuters Staff (Reuters) - U.S. regulators on Monday authorized Pfizer and BioNTech's COVID-19 vaccine for use in children as young as 12, widening the country's inoculation program as vaccination Read More »

Novavax delays COVID-19 vaccine production timeline, sees filing for authorization in 3rd qtr

By Trisha Roy and Carl O'Donnell (Reuters) - Novavax Inc said on Monday production of its COVID-19 vaccine will ramp up at a slower pace than it had previously anticipated and it does not expect to Read More »

Pediatric gastroenteritis protection similar with Rotarix and RotaTeq vaccines

By Lisa Rapaport (Reuters Health) - Both vaccines for rotavirus, Rotarix and RotaTeq, provide a similar reduction in rotavirus gastroenteritis risk in children under 5 years old, a new systematic Read More »

Soft, flexible sensors can wirelessly monitor pregnant women and their fetuses

By Linda Carroll (Reuters Health) - An interdisciplinary team of scientists has developed a wireless network of three soft, flexible sensors that can measure the vital signs of a laboring mother and Read More »

Alpha-2 adrenergic agonists tied to fewer side effects when treating ADHD in young children

By Marilynn Larkin NEW YORK (Reuters Health) - Both alpha-2 adrenergic agonists and stimulants were associated with improvement in attention-deficit/hyperactivity disorder (ADHD) in preschool children Read More »

Immediate treatment of M. abscessus urged for cystic fibrosis

By Marilynn Larkin NEW YORK (Reuters Health) - An analysis of whole genome data from cystic fibrosis patients reveals how multi-drug resistant pathogens evolve and suggests that Mycobacterium Read More »

See all news »

Clinical Trials

Use our ClinicalTrials.gov feed to find trials in which your patients could enroll. In some cases, experimental drugs are a patient’s only hope. This section will regularly report on trials in the most common disease states, as they are getting underway.


© 2021 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information